Skip to main content
Clinical Trials/NCT03100994
NCT03100994
Unknown
Phase 4

Post-operative Analgesia Efficacy Using Ultrasound-guided Transmuscular Quadratus Lumborum Block Versus Ultrasound-guided Quadratus Lumborum Type II Block.

Tri-Service General Hospital1 site in 1 country180 target enrollmentMarch 28, 2017

Overview

Phase
Phase 4
Intervention
Bupivacaine
Conditions
Nerve Block
Sponsor
Tri-Service General Hospital
Enrollment
180
Locations
1
Primary Endpoint
morphine consumption
Last Updated
9 years ago

Overview

Brief Summary

Post-operative analgesia efficacy using ultrasound-guided transmuscular quadratus lumborum block versus ultrasound-guided quadratus lumborum type II block

Detailed Description

The Quadratus Lumborum (QL) Block is an ultrasound-guided technique described by Rafael Blanco in 2007. The nerves to the lower abdominal wall can be anesthetized by injecting local anesthetics between the quadratus lumborum muscle and latissimus dorsi muscle, which is called quadratus lumborum type II block. 〝 Transmuscular quadratus lumborum block demonstrates that injectate spreads over the posterior abdominal wall to the psoas major muscle and includes the upper branches of the lumbar plexus.〞described by Adhikary in 2016. However there are no published reports comparing the 2 techniques. In our study, compared of ultrasound-guided QL2-blocks with transmuscular quadratus lumborum block to investigate analgesic consumption, pain level, opioid related side effects and mobilization.

Registry
clinicaltrials.gov
Start Date
March 28, 2017
End Date
July 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wu Hsuan-Cheng

Principal Investigator, Department of Anesthesiology,Tri-ServiceGeneralHospital

Tri-Service General Hospital

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists classification (ASA) 1\~3
  • adequate communication skills
  • Body mass index \< 32

Exclusion Criteria

  • chronic pain neurological illness/ neuropathy contraindication against local anesthetics

Arms & Interventions

Group B

Ultrasound guided transmuscular quadratus lumborum block with 0.125% bupivacaine 30ml

Intervention: Bupivacaine

Group B

Ultrasound guided transmuscular quadratus lumborum block with 0.125% bupivacaine 30ml

Intervention: Ultrasound

Group C

Ultrasound guided quadratus lumborum type 2 block with 0.125% bupivacaine 30ml

Intervention: Bupivacaine

Group C

Ultrasound guided quadratus lumborum type 2 block with 0.125% bupivacaine 30ml

Intervention: Ultrasound

Outcomes

Primary Outcomes

morphine consumption

Time Frame: 48 hours

morphine consumption

Secondary Outcomes

  • Nausea or vomiting(48 hours)
  • Skin itch(48 hours)
  • Severity of postoperative pain via visual analogue pain scale (VAS)(48 hours)
  • time to mobilization(48 hours)

Study Sites (1)

Loading locations...

Similar Trials